Dental pulp regeneration models have become a cornerstone of translational research in endodontics, enabling the development and assessment of novel regenerative therapies. This review critically examines the types, mechanisms, and clinical significance of current dental pulp regeneration models, integrating recent evidence and guideline-based perspectives. Emphasis is placed on the epidemiological context, pathophysiological mechanisms, risk factors, clinical presentations, diagnostic strategies, and management protocols, along with an analysis of emerging technologies and regulatory recommendations. The synthesis aims to provide healthcare professionals with a comprehensive and clinically relevant overview to facilitate the translation of regenerative endodontic principles into patient care.
The loss of dental pulp vitality due to caries, trauma, or iatrogenic factors presents a significant challenge in dental practice. Traditional root canal therapy, though effective in removing infection, fails to restore the biological and immunological functions of the pulp-dentin complex. In recent years, the advent of regenerative endodontics has shifted the paradigm towards restoring pulp tissue structure and function. Dental pulp regeneration models, spanning in vitro, ex vivo, and in vivo systems, are pivotal in understanding the cellular and molecular dynamics of regeneration, evaluating biomaterials, and validating new therapeutic approaches prior to clinical application. This article reviews these models, highlighting their scientific rationale, clinical relevance, and future directions.
Pulpal and periapical diseases remain a global oral health concern, with dental caries affecting over 2.4 billion people worldwide and traumatic injuries accounting for substantial morbidity in children and adolescents. The prevalence of pulpal necrosis and the subsequent need for endodontic intervention is notably high, particularly in populations with limited access to preventive care. Epidemiological data underscore the necessity for regenerative strategies to address the limitations of conventional therapies and meet the unmet clinical needs of diverse patient populations.
The pathophysiology of pulp necrosis involves a complex interplay between microbial invasion, host immune response, and tissue breakdown. Loss of vascular supply following infection or trauma results in hypoxia, apoptosis of pulp cells, and subsequent pulp chamber obliteration. The intrinsic regenerative capacity of the pulp is hindered by progressive inflammation and matrix degradation. Regenerative models seek to recapitulate the native pulp microenvironment, leveraging stem cell biology, growth factor gradients, and biomimetic scaffolds to promote angiogenesis, neurogenesis, and tissue remodeling.
Risk factors for pulpal necrosis and the need for regeneration include deep dental caries, extensive restorative procedures, traumatic dental injuries, developmental anomalies, and genetic predispositions affecting dentin-pulp complex resilience. Systemic conditions such as diabetes mellitus or immunosuppression may further compromise pulpal healing and regenerative potential. Understanding these risk factors is essential for patient stratification and tailoring regenerative interventions.
Clinically, irreversible pulpitis and necrosis present as spontaneous pain, sensitivity to thermal stimuli, discoloration of the crown, swelling, and sinus tract formation. In regenerative endodontics, the goal is not only symptomatic relief but also restoration of pulp vitality, immunocompetence, and continued root development in immature teeth. Monitoring clinical features post-regeneration includes assessment of pulp sensibility, radiographic evidence of apical closure, and absence of periapical pathology.
Diagnosis of pulpal status relies on a combination of clinical examination, sensibility testing (thermal, electric), and radiographic imaging. Advanced diagnostic modalities, such as cone-beam computed tomography (CBCT) and molecular biomarkers, are increasingly being integrated to assess pulp necrosis and regeneration outcomes. In preclinical and clinical regeneration studies, histological analysis remains the gold standard for evaluating true pulp tissue formation and integration with host tissues.
Current regenerative endodontic protocols involve disinfecting the root canal system with minimal instrumentation, followed by intracanal medicaments (e.g., calcium hydroxide, triple antibiotic paste) to reduce microbial load. The induction of bleeding or placement of stem cell-laden scaffolds promotes cell homing and tissue regeneration. Bioactive materials such as mineral trioxide aggregate (MTA) or bioceramic cements are used to seal the canal, supporting the regeneration process. Patient selection, procedural standardization, and outcome assessment are critical for clinical success.
Recent years have witnessed significant advancements in dental pulp regeneration models. Three-dimensional (3D) organotypic cultures, microfluidic chips, and humanized animal models have enhanced the physiological relevance of preclinical studies. Induced pluripotent stem cell (iPSC) technology, gene editing tools like CRISPR/Cas9, and bioengineered scaffolds incorporating growth factors (e.g., BMPs, VEGF) are at the forefront of translational research. These models facilitate the study of cell-matrix interactions, immunomodulation, and vascularization, which are critical for successful regeneration. Clinical trials employing autologous dental pulp stem cells (DPSCs) and allogenic cell therapies are underway, heralding a new era in personalized regenerative endodontics.
International guidelines, including those from the American Association of Endodontists (AAE) and the European Society of Endodontology (ESE), advocate for the use of regenerative procedures in immature permanent teeth with necrotic pulps, emphasizing case selection, minimal mechanical disruption, and stringent infection control. The guidelines underscore the necessity of long-term follow-up, standardized outcome measures, and informed consent regarding the experimental nature of many regenerative interventions. Ongoing updates are informed by accumulating clinical evidence and advances in regenerative biology.
Dental pulp regeneration models serve as an essential bridge between bench research and clinical application, providing insights into the mechanisms and therapeutic potential of regenerative endodontics. The integration of advanced cellular, molecular, and bioengineering techniques continues to refine these models, enhancing their translational value. As evidence accumulates and guidelines evolve, clinicians are better equipped to incorporate regenerative strategies into practice, ultimately improving patient outcomes and preserving natural dentition. Ongoing interdisciplinary collaboration will be critical in addressing current limitations and realizing the full potential of dental pulp regeneration in restorative dentistry.
1.
New Nanoparticles Can Destroy Undruggable Cancer Proteins
2.
Brain MRI Surveillance Alone Helps Preserve Cognition in Small Cell Lung Cancer
3.
NEET SS Counseling 2023: MCC provides information on DNB SS Medical Oncology seats available at ESIC Medical College and Hospital Faridabad.
4.
Belzutifan Plus Pembro Approved for Adjuvant RCC
5.
Using MRD Status to Deescalate Multiple Myeloma Therapy
1.
Diagnosis and Treatment of Follicular Thyroid Cancer: A Comprehensive Guide
2.
Obesity as a major risk factor for cancer
3.
Unraveling the Genetic Mystery of Hereditary Spherocytosis
4.
Advanced Pathways in Oncology for Better Care
5.
Essential Updates in Hematology in Daily Practice
1.
International Conference on Oncology, Cancer Prevention and Public Health
2.
International Conference on Cancer Nursing and Rehabilitation Strategies
3.
International Conference on Best Practices in Oncology, Cardiology and Critical Care
4.
International Conference on Innovations in Critical Care for Oncology and Cardiology
5.
International Symposium on Oncology, Cardiology and Critical Care Innovations
1.
Guideline Recommendations of Lorlatinib as First-Line Treatment for ALK+ NSCLC
2.
Breaking Ground: ALK-Positive Lung Cancer Front-Line Management - Part I
3.
Understanding Anemia and Its Common Causes
4.
Targeting Oncologic Drivers with Dacomitinib: Further Discussion on Lung Cancer Treatment
5.
Early Cancer Detection Saves Lives
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation